India · Delayed Price · Currency is INR Morepen Laboratories Statistics
Total Valuation
NSE:MOREPENLAB has a market cap or net worth of INR 21.24 billion. The enterprise value is 22.02 billion.
| Market Cap | 21.24B |
| Enterprise Value | 22.02B |
Important Dates
The last earnings date was Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 547.95M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.57% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 308.76M |
Valuation Ratios
The trailing PE ratio is 21.36.
| PE Ratio | 21.36 |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 22.14 |
| EV / Sales | 1.23 |
| EV / EBITDA | 19.58 |
| EV / EBIT | 22.88 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.41 |
| Debt / FCF | n/a |
| Interest Coverage | 5.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.78% |
| Revenue Per Employee | 9.85M |
| Profits Per Employee | 548,223 |
| Employee Count | 1,814 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:MOREPENLAB has paid 220.91 million in taxes.
| Income Tax | 220.91M |
| Effective Tax Rate | 18.06% |
Stock Price Statistics
The stock price has decreased by -24.73% in the last 52 weeks. The beta is 0.63, so NSE:MOREPENLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -24.73% |
| 50-Day Moving Average | 38.98 |
| 200-Day Moving Average | 50.57 |
| Relative Strength Index (RSI) | 51.88 |
| Average Volume (20 Days) | 2,046,108 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MOREPENLAB had revenue of INR 17.87 billion and earned 994.48 million in profits. Earnings per share was 1.81.
| Revenue | 17.87B |
| Gross Profit | 6.17B |
| Operating Income | 962.69M |
| Pretax Income | 1.22B |
| Net Income | 994.48M |
| EBITDA | 1.01B |
| EBIT | 962.69M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 808.74 million in cash and 1.58 billion in debt, with a net cash position of -775.88 million.
| Cash & Cash Equivalents | 808.74M |
| Total Debt | 1.58B |
| Net Cash | -775.88M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.97B |
| Book Value Per Share | 21.77 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 34.53%, with operating and profit margins of 5.39% and 5.57%.
| Gross Margin | 34.53% |
| Operating Margin | 5.39% |
| Pretax Margin | 6.85% |
| Profit Margin | 5.57% |
| EBITDA Margin | 5.64% |
| EBIT Margin | 5.39% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.57% |
| Shareholder Yield | -4.04% |
| Earnings Yield | 4.68% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2000. It was a forward split with a ratio of 5.
| Last Split Date | Nov 6, 2000 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |